These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 29133355)

  • 21. Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.
    Muntner P; Carey RM; Gidding S; Jones DW; Taler SJ; Wright JT; Whelton PK
    Circulation; 2018 Jan; 137(2):109-118. PubMed ID: 29133599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension.
    Chiang CE; Wang TD; Li YH; Lin TH; Chien KL; Yeh HI; Shyu KG; Tsai WC; Chao TH; Hwang JJ; Chiang FT; Chen JH;
    J Formos Med Assoc; 2010 Oct; 109(10):740-73. PubMed ID: 20970072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials.
    Shaman AM; Smyth B; Arnott C; Palmer SC; Mihailidou AS; Jardine MJ; Gallagher MP; Perkovic V; Jun M
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1129-1138. PubMed ID: 32675281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.
    Muntner P; Carey RM; Gidding S; Jones DW; Taler SJ; Wright JT; Whelton PK
    J Am Coll Cardiol; 2018 Jan; 71(2):109-118. PubMed ID: 29146532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical Therapy for Systemic Right Ventricles: A Systematic Review (Part 1) for the 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Zaragoza-Macias E; Zaidi AN; Dendukuri N; Marelli A
    Circulation; 2019 Apr; 139(14):e801-e813. PubMed ID: 30586770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them.
    Jiao Y; Sun Z; Xie Y; Zheng J; Li Z; Guo X; Dai Y; Zheng L; Sun Y
    BMC Cardiovasc Disord; 2020 May; 20(1):237. PubMed ID: 32429909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.
    Pandey A; Patel KV; Vongpatanasin W; Ayers C; Berry JD; Mentz RJ; Blaha MJ; McEvoy JW; Muntner P; Vaduganathan M; Correa A; Butler J; Shimbo D; Nambi V; deFilippi C; Seliger SL; Ballantyne CM; Selvin E; de Lemos JA; Joshi PH
    Circulation; 2019 Dec; 140(25):2076-2088. PubMed ID: 31707797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guideline on Contemporary Practice: A Cross-Sectional Analysis From NCDR PINNACLE Registry.
    Hussain A; Virani SS; Zheng L; Gluckman TJ; Borden WB; Masoudi FA; Maddox TM
    J Am Heart Assoc; 2022 Jun; 11(11):e024107. PubMed ID: 35656989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabolic goals.
    Gijón-Conde T; Sánchez-Martínez M; Graciani A; Cruz JJ; López-García E; Ortolá R; Rodríguez-Artalejo F; Banegas JR
    J Hypertens; 2019 Jul; 37(7):1393-1400. PubMed ID: 31145710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.
    Carey RM; Calhoun DA; Bakris GL; Brook RD; Daugherty SL; Dennison-Himmelfarb CR; Egan BM; Flack JM; Gidding SS; Judd E; Lackland DT; Laffer CL; Newton-Cheh C; Smith SM; Taler SJ; Textor SC; Turan TN; White WB;
    Hypertension; 2018 Nov; 72(5):e53-e90. PubMed ID: 30354828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline.
    Carey RM; Whelton PK;
    Ann Intern Med; 2018 Mar; 168(5):351-358. PubMed ID: 29357392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    ; Bittl JA; Baber U; Bradley SM; Wijeysundera DN
    Circulation; 2016 Sep; 134(10):e156-78. PubMed ID: 27026019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of ambulatory blood pressure phenotypes using the 2017 American College of Cardiology/American Heart Association blood pressure guideline thresholds: data from the Coronary Artery Risk Development in Young Adults study.
    Poudel B; Booth JN; Sakhuja S; Moran AE; Schwartz JE; Lloyd-Jones DM; Lewis CE; Shikany JM; Shimbo D; Muntner P
    J Hypertens; 2019 Jul; 37(7):1401-1410. PubMed ID: 31145711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure--meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2016 Mar; 34(3):373-84; discussion 384. PubMed ID: 26780184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lowering the systolic blood pressure target in hypertensive patients: current controversies and future outlook.
    Narita K; Hoshide S; Kario K
    Expert Rev Cardiovasc Ther; 2018 Dec; 16(12):889-895. PubMed ID: 30358459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension.
    Chen JM; Heran BS; Perez MI; Wright JM
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007185. PubMed ID: 20091622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.